Angiodynamics Inc (ANGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
| 05-2025 | 05-2024 | 05-2023 | 05-2022 | 05-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,893 | 76,056 | 44,620 | 28,825 | 48,161 |
| Receivables | 42,890 | 43,610 | 52,826 | 52,304 | 35,405 |
| Inventories | 62,006 | 60,616 | 55,325 | 51,392 | 48,614 |
| Other current assets | 0 | 0 | 6,154 | 0 | 0 |
| TOTAL | $168,324 | $193,253 | $163,542 | $143,345 | $140,879 |
| Non-Current Assets | |||||
| PPE Net | 32,300 | 35,666 | 44,384 | 45,005 | 37,073 |
| Intangibles | 69,116 | 77,383 | 270,382 | 353,438 | 370,293 |
| Other Non-Current Assets | 10,404 | 11,369 | 54,329 | 10,963 | 13,193 |
| TOTAL | $111,820 | $124,418 | $369,095 | $409,406 | $420,559 |
| Total Assets | $280,144 | $317,671 | $532,637 | $552,751 | $561,438 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 33,291 | 37,751 | 40,445 | 28,047 | 19,630 |
| Accrued Expenses | 35,518 | 41,098 | 26,617 | 34,842 | 35,459 |
| Other current liabilities | 7,388 | 12,306 | 16,763 | 11,435 | 2,495 |
| TOTAL | $76,197 | $91,155 | $83,825 | $74,324 | $57,584 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 49,818 | 25,000 | 20,000 |
| Other Non-Current Liabilities | 16,904 | 16,078 | 7,885 | 12,901 | 24,442 |
| TOTAL | $20,977 | $20,930 | $70,516 | $53,938 | $64,397 |
| Total Liabilities | $97,174 | $112,085 | $154,341 | $128,262 | $121,981 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,634 | 40,277 | 39,671 | 38,970 | 38,444 |
| Common Shares | 385 | 385 | 382 | 380 | 377 |
| Retained earnings | -429,197 | -395,204 | -210,855 | -158,413 | -131,866 |
| Other shareholders' equity | -2,404 | -4,079 | -4,437 | 1,643 | 3,439 |
| TOTAL | $182,970 | $205,586 | $378,296 | $424,489 | $439,457 |
| Total Liabilities And Equity | $280,144 | $317,671 | $532,637 | $552,751 | $561,438 |